ENTITY

Oncimmune Holdings (ONC LN)

3
Analysis
Health CareUnited Kingdom
Oncimmune Limited develops and commercializes products for the detection of cancerous. It develops autoantibody assay technologies that have the potential to early detection a range of solid cancer tumor types. It offers EarlyCDT-Lung, a blood test that is ordered by a doctor to aid in the risk assessment and early detection of lung cancer in high-risk patients and to stratify indeterminate pulmonary nodules for the risk of malignancy. The company is based in Nottingham, the United Kingdom.
more
Exchange Announcement26 Mar 2025 20:45
Exchange Announcement19 Mar 2025 15:00
Exchange Announcement17 Mar 2025 15:00
Exchange Announcement10 Mar 2025 21:39
Exchange Announcement28 Feb 2025 00:18
x